Compounds > copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine
Page last updated: 2024-12-08
copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine
Description
copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine: catalytic reagent for oxidation of ascorbic acid; RN given refers to dinitrate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 171085 |
MeSH ID | M0125343 |
Synonyms (6)
Synonym |
copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine |
51890-18-7 |
cu(taab) |
cu(taab)cl2 |
copper(2+), (tetrabenzo(b,f,j,n)(1,5,9,13)tetraazacyclohexadecine-n5,n11,n17,n23)-, (sp-4-1)-, dinitrate |
tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine copper |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.78
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.78 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.72 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |